ZYPREXA

H2-Pharma LLC🇺🇸 United States

FDA Page

Effective Date: May 19, 2026
Approval ID: 11544cba-64a9-49cb-8d74-da228053b252
Products: 3 registered
Version: 68

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ZYPREXA RELPREVV safely and effectively. See full prescribing information for ZYPREXA RELPREVV.ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable SuspensionInitial U.S. Approval: 1996

Quick Stats

Total Products3

Labelers2

Label Sections44

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.